Biopharmaceutical

Results: 492



#Item
71Microsoft Word - FDA Arthritis Advisory Committee Recommends Approvaldoc

Microsoft Word - FDA Arthritis Advisory Committee Recommends Approvaldoc

Add to Reading List

Source URL: www.mvpharm.com

Language: English - Date: 2016-07-11 16:55:40
72ABIRISK Making novel drugs safer for patients A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments

ABIRISK Making novel drugs safer for patients A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments

Add to Reading List

Source URL: www.abirisk.eu

Language: English - Date: 2012-11-23 07:10:19
73Capabilities Overview RESPONSIVE. RELIABLE. RESOURCEFUL. Cytovance® Biologics is a leading contract development and manufacturing provider of both mammalian and microbial service offerings to the

Capabilities Overview RESPONSIVE. RELIABLE. RESOURCEFUL. Cytovance® Biologics is a leading contract development and manufacturing provider of both mammalian and microbial service offerings to the

Add to Reading List

Source URL: www.cytovance.com

Language: English - Date: 2015-09-30 11:06:08
74www.medscape.com/viewarticle/864011_print www.medscape.com

www.medscape.com/viewarticle/864011_print www.medscape.com

Add to Reading List

Source URL: digestivehealthfoundation.org

Language: English - Date: 2016-08-09 08:21:07
75OFFICE OF SCIENCE AND TECHNOLOGY POLICY AGENCY: Executive Office of the President, Office of Science and Technology Policy. 51 FRJune 26, 1986 Coordinated Framework for Regulation of Biotechnology ACTION: Announce

OFFICE OF SCIENCE AND TECHNOLOGY POLICY AGENCY: Executive Office of the President, Office of Science and Technology Policy. 51 FRJune 26, 1986 Coordinated Framework for Regulation of Biotechnology ACTION: Announce

Add to Reading List

Source URL: www.aphis.usda.gov

Language: English - Date: 2004-06-25 11:08:48
76January 14, 2016 Horizon Pharma plc Completes Acquisition of Crealta Holdings LLC DUBLIN, IRELAND -- (MarketwiredHorizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patie

January 14, 2016 Horizon Pharma plc Completes Acquisition of Crealta Holdings LLC DUBLIN, IRELAND -- (MarketwiredHorizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patie

Add to Reading List

Source URL: www.mvpharm.com

Language: English - Date: 2016-07-13 15:47:47
    77Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property Cambridge, UK: 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics,

    Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property Cambridge, UK: 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics,

    Add to Reading List

    Source URL: www.crescendobiologics.com

    Language: English - Date: 2016-04-15 08:53:48
    78JUNE 2016 TABLE OF CONTENTS INTRODUCTION

    JUNE 2016 TABLE OF CONTENTS INTRODUCTION

    Add to Reading List

    Source URL: www.abirisk.eu

    Language: English - Date: 2016-07-15 09:12:19
    79Fill and Finish Overview RESPONSIVE. RELIABLE. RESOURCEFUL. Cytovance® Biologics is a leading contract development and manufacturing provider of both mammalian and microbial service offerings to the

    Fill and Finish Overview RESPONSIVE. RELIABLE. RESOURCEFUL. Cytovance® Biologics is a leading contract development and manufacturing provider of both mammalian and microbial service offerings to the

    Add to Reading List

    Source URL: www.cytovance.com

    Language: English - Date: 2015-09-30 11:06:08
    80

    PDF Document

    Add to Reading List

    Source URL: www.managingip.com

    Language: English - Date: 2015-10-13 04:59:55